Skip to main navigation
logo
Investors
  • News Archive
  • Past Events and Presentations
  • Stock History

News Archive

News Archive

Jul 06, 2020
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients
Jun 30, 2020
Mylan Shareholders Overwhelmingly Approve Proposed Combination with Upjohn
Jun 18, 2020
Mylan Wins District Court Decision Against Biogen's Tecfidera® Patent
Jun 11, 2020
Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)
Jun 04, 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
May 29, 2020
Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings
May 13, 2020
Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference
May 12, 2020
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
May 11, 2020
Mylan Reports First Quarter 2020 Results and Reaffirms 2020 Guidance
May 08, 2020
Mylan to Present at the BofA Securities Virtual Health Care Conference 2020

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »
Share

Utility Nav

  • Privacy Statement
  • Terms and Conditions
©2023 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.
mylan